Dear Sir,
We read with a great interest the excellent article by Chien et al.
(1) demonstrating that vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis in acute myeloid leukemic (AML) cells by induction of cyclooxygenase (COX)-2 and the subsequent prostaglandin E 2 production. This very interesting study answers a currently unsolved question: Why only a subset of AML blasts express COX-2? During the past decade, several studies have reported the involvement of lipid mediators (including COX-derived metabolites) on the growth of human myeloid/erythroid progenitors and blood cell lines (2,3). More recently, freshly isolated AML blasts were reported to secrete prostaglandin E 2 (4) and to express functional EP 2 receptors (5,6). While AML blasts expressed COX-2 transcripts but not the corresponding protein (4), lipopolysaccharide stimulated COX-2 protein expression through the toll-like receptor-4 pathway in a subset of AML blasts (7). Chien et al. (1) reported that 50% of bone marrow specimens from AML patients express COX-2 with a strong correlation between COX-2 and VEGF-C. Of interest, the expression of VEGF-C and VEGF receptors is positively regulated by LPS in HL-60 cells (a M 2-3 AML cell line) during macrophage differentiation (8). In conclusion, past studies have highlighted that lipidic mediators might act on tumor growth by altering the local cytokine network (9, 10) . The interesting study of Chien et al. (1) returns the situation and shows that angiogenic factors (such as VEGF-C) might act on tumor growth by altering the lipidic network.
